Investigating how tau protein affects brain cells in Alzheimer's disease
Tau-induced astrocyte senescence in Alzheimer's disease
This study is looking at how a specific brain cell type called astrocytes is affected by a protein linked to Alzheimer's disease, with the hope of finding new ways to help people with the condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Oklahoma Hlth Sciences Ctr NIH-funded |
| Lab location | 1 site (Oklahoma City, United States) |
| Project ID | NIH-10875699 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of astrocytes, a type of brain cell, in Alzheimer's disease, particularly how they are affected by tau protein. The study examines how abnormal tau protein accumulates in astrocytes and leads to cellular aging, which may contribute to the progression of Alzheimer's. By exploring the mechanisms of tau transmission between neurons and astrocytes, the research aims to uncover new insights into how aging and Alzheimer's disease are linked. Patients may benefit from this research as it could lead to new therapeutic strategies targeting astrocyte function in Alzheimer's.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at risk for developing it.
Not a fit: Patients with other forms of dementia unrelated to Alzheimer's may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide new insights into potential treatments that target astrocyte dysfunction in Alzheimer's disease.
How similar studies have performed: While the specific approach of targeting astrocyte senescence in Alzheimer's is relatively novel, previous research has shown that targeting tau pathology can lead to significant advancements in understanding and treating Alzheimer's disease.
Where this research is happening
Oklahoma City, United States
- University of Oklahoma Hlth Sciences Ctr — Oklahoma City, United States (Active)
Researchers
- Principal investigator: Galvan, Veronica — University of Oklahoma Hlth Sciences Ctr
- Study coordinator: Galvan, Veronica
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.